Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-29

Clinical Trial Update: Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD). [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating resilience-based interventions (PRISM) and narrative-focused care (CFN) in adults with primary mitochondrial disease has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Mitochondrial Diseases, Mitochondrial Myopathies | Phase 1, Phase 2 | Status: COMPLETED